Review summary
Teaching objective: Secondary prevention in the first months after a non-ST-elevation myocardial infarction in a 62-year-old Black woman, an entertainer, veteran and civil rights activist under heavy financial strain, seen three weeks after a stent with breathlessness on exertion. The episode covers the care women, and Black women in particular, are less likely to receive after a heart attack, as AHA statements and registry data show: a full cardiology review, echocardiography, cardiac rehabilitation and every guideline-directed medicine. It teaches dual antiplatelet therapy for twelve months, recognizing ticagrelor-related breathlessness and switching to clopidogrel with a loading dose rather than stopping; high-intensity atorvastatin with an LDL goal below 70 mg/dL and a single lipoprotein(a) measurement; a beta-blocker for the first year and an ACE inhibitor for high blood pressure, with potassium and kidney checks (one missed check recorded honestly); depression screening after a heart attack with the PHQ-2 and PHQ-9, as the AHA advises; a nosebleed on dual antiplatelet therapy managed without stopping it; a graded return to the stage after an exercise test; the hysterectomy of her thirties as a possible early menopause and a risk-enhancing factor; and trauma-informed, respectful care that takes her account of her body seriously, under the 1966 AHA/ACC chronic coronary disease guideline, the 1968 ACC/AHA acute coronary syndromes guideline and the AHA statement on myocardial infarction in women.
Historical timeline
| Date | Event | Claims |
|---|---|---|
| June 3, 1906 | Born Freda Josephine McDonald in St. Louis, Missouri. | CLM-0001, CLM-0002 |
| 1925 | Comes to Paris with her troupe and performs at the Théâtre des Champs-Elysées. | CLM-0003 |
| 1937 | Marries a Frenchman and becomes a French citizen. | CLM-0004 |
| June 1941 | Taken urgently to hospital in Casablanca after the loss of a pregnancy; in bed until December 1942, with five operations. | CLM-0007, CLM-0008 |
| 1954 to 1965 | Adopts twelve children, raised at Les Milandes. | CLM-0006 |
| August 18, 1961 | Receives the Legion of Honor and the Croix de guerre with palm for her Resistance work. | CLM-0005 |
| August 28, 1963 | Speaks at the March on Washington for Jobs and Freedom. | CLM-0009 |
| June 2, 1964 | Televised appeal for donations to save Les Milandes from its debts. | CLM-0010 |
| March 1969 | Evicted from Les Milandes; has a heart attack the same day and is admitted to hospital in Périgueux. | CLM-0011 |
| 1973 | Heart attack and stroke after a concert in Copenhagen. | CLM-0012 |
| April 12, 1975 | Dies in Paris of a cerebral hemorrhage, days after the opening of her fiftieth-anniversary revue at Bobino. | CLM-0013 |
| November 30, 2021 | Enters the Panthéon. | CLM-0014 |
Evidence claims
D = documented, R = retrospective, S = synthetic.
| Grade | Claim | Certainty | Sources |
|---|---|---|---|
| D | She was born Freda Josephine McDonald on June 3, 1906, in St. Louis, Missouri, to Carrie McDonald and Eddie Carson, into a family with little money. Anchors the true birth date and the alias. |
confirmed | Josephine Baker supports Joséphine Baker (Chemins de mémoire: personnalités) supports Josephine Baker supports HISTMED Master Roster v3 supports |
| D | She grew up in poor neighborhoods of St. Louis and began working as a child; she married twice before the age of 16 and kept the surname of her second husband, William Howard Baker. Social history only; the hardship of her childhood informs trauma-informed care. |
confirmed | Josephine Baker supports Joséphine Baker (Chemins de mémoire: personnalités) supports |
| D | She danced in New York in the musicals Shuffle Along and The Chocolate Dandies, came to Paris with her troupe in 1925 to perform at the Théâtre des Champs-Elysées, and became the most famous and highest-paid American performer in France. Anchors her occupation as a performer in the modern social history. |
confirmed | Josephine Baker supports Joséphine Baker (Chemins de mémoire: personnalités) supports |
| D | She married a Frenchman in 1937 and became a French citizen; the National Park Service gives 1936. The French Ministry of the Armed Forces and La Croix give 1937; the National Park Service page gives 1936. The record uses 1937. |
probable | Joséphine Baker (Chemins de mémoire: personnalités) supports Raspiengeas JC. Joséphine Baker: les mille vies du Phénix (dossier). La Croix L'Hebdo, November 2021 supports Josephine Baker disputes |
| D | During the Second World War she worked for the intelligence services of Free France with the rank of sub-lieutenant, gathering information and carrying messages written in invisible ink on her sheet music; on August 18, 1961, she received the Legion of Honor and the Croix de guerre with palm. Anchors her strengths and her standing as a veteran in the modern social history. |
confirmed | Joséphine Baker (Chemins de mémoire: personnalités) supports Raspiengeas JC. Joséphine Baker: les mille vies du Phénix (dossier). La Croix L'Hebdo, November 2021 supports Josephine Baker (Feminism and French Women in History: famous French women) supports |
| D | She bought a château at Les Milandes in the Périgord, where she made a "village of the world" and raised twelve children of different nationalities and religions whom she had adopted during her tours with Jo Bouillon, her husband; the children were called the "Rainbow Tribe". Documented history only; the children are not named in this record because some are living. Twelve is the number given by La Croix and by Women in World History (ten boys and two girls, adopted from 1954 to 1965); the National Women's History Museum gives 13. |
probable | Joséphine Baker (Chemins de mémoire: personnalités) supports Raspiengeas JC. Joséphine Baker: les mille vies du Phénix (dossier). La Croix L'Hebdo, November 2021 supports Ojala JA. Baker, Josephine (1906-1975). Women in World History: A Biographical Encyclopedia supports Josephine Baker (biography) disputes |
| D | In North Africa during the war she was taken urgently to hospital in Casablanca, where she stayed in bed from June 1941 to December 1942, had five operations and was several times reported to be dying; she continued her intelligence work from her room. The documented anchor for her long, grave illness; the dates and the number of operations come from La Croix, and Women in World History agrees that she was critically ill and had several operations. |
probable | Raspiengeas JC. Joséphine Baker: les mille vies du Phénix (dossier). La Croix L'Hebdo, November 2021 supports Ojala JA. Baker, Josephine (1906-1975). Women in World History: A Biographical Encyclopedia supports |
| R | The illness followed the loss of a pregnancy in 1941, given as a stillbirth in Casablanca by one source and as a miscarriage by another; the second account says a severe infection required a hysterectomy, after which she developed peritonitis and septicemia. La Croix says she was unable to have children. Retrospective and partly conflicting account: stillbirth (Women in World History) or miscarriage (Women's History Network); the hysterectomy, peritonitis and septicemia rest on the Women's History Network alone. Whether her ovaries were removed is not recorded in any source read. Used, with this uncertainty, for the gynecologic history and the cardiovascular risk discussion. |
possible | Ojala JA. Baker, Josephine (1906-1975). Women in World History: A Biographical Encyclopedia supports Munro S. Josephine Baker (1906-1975). Women's History Network blog supports Raspiengeas JC. Joséphine Baker: les mille vies du Phénix (dossier). La Croix L'Hebdo, November 2021 supports |
| D | At the March on Washington for Jobs and Freedom on August 28, 1963, she was one of the few women to speak; she came in her military uniform with her decorations. Anchors her civil rights work in the modern social history. |
confirmed | Josephine Baker supports Raspiengeas JC. Joséphine Baker: les mille vies du Phénix (dossier). La Croix L'Hebdo, November 2021 supports Josephine Baker (biography) supports |
| D | Les Milandes ran into heavy debt; she toured repeatedly to pay it, and on June 2, 1964, she made a televised appeal for donations, saying her work no longer covered debts of about 200 million old francs. Anchors the financial strain in the modern social history. |
confirmed | Call for donations from Josephine Baker for the safeguarding of her castle in the Dordogne (television clip, June 2, 1964) supports Raspiengeas JC. Joséphine Baker: les mille vies du Phénix (dossier). La Croix L'Hebdo, November 2021 supports |
| D | In March 1969, after a court ordered her eviction, she was removed from the château and sat for seven hours in the rain on its steps; she had a new heart attack and ended the day in hospital in Périgueux. Les Milandes was sold at auction that year. The documented anchor for the heart attack in the modern episode. The heart attack rests on La Croix alone and is called a new one, implying an earlier one that the sources read do not date. A heart attack in 1964, often repeated online, was not found in any reliable source and is not used. |
probable | Raspiengeas JC. Joséphine Baker: les mille vies du Phénix (dossier). La Croix L'Hebdo, November 2021 supports Ojala JA. Baker, Josephine (1906-1975). Women in World History: A Biographical Encyclopedia supports |
| D | She was hospitalized several times for heart attacks and cerebral emboli in her last years; after a concert in Copenhagen in 1973 she had a heart attack and a stroke. Later history, after the modern episode. |
probable | Raspiengeas JC. Joséphine Baker: les mille vies du Phénix (dossier). La Croix L'Hebdo, November 2021 supports Ojala JA. Baker, Josephine (1906-1975). Women in World History: A Biographical Encyclopedia supports |
| D | On April 8, 1975, at Bobino in Paris, a revue celebrating her fifty years on the stage opened to a long ovation; a few days later she was found unconscious and she died in hospital in Paris of a cerebral hemorrhage on April 12, 1975, aged 68. Women in World History gives April 14. The cause of death is a stroke from bleeding in the brain, not a heart attack. The date April 12 is given by the National Park Service, the Women's History Network and Biography.com; April 14 is recorded as a conflict. |
probable | Raspiengeas JC. Joséphine Baker: les mille vies du Phénix (dossier). La Croix L'Hebdo, November 2021 supports Munro S. Josephine Baker (1906-1975). Women's History Network blog supports Josephine Baker supports Josephine Baker supports Joséphine Baker (Chemins de mémoire: personnalités) supports Ojala JA. Baker, Josephine (1906-1975). Women in World History: A Biographical Encyclopedia disputes HISTMED Master Roster v3 supports |
| D | She is buried in Monaco; on November 30, 2021, she entered the Panthéon in Paris, the first Black woman to do so, with a cenotaph carried by air force personnel. History after her death. |
confirmed | Joséphine Baker (Chemins de mémoire: personnalités) supports Raspiengeas JC. Joséphine Baker: les mille vies du Phénix (dossier). La Croix L'Hebdo, November 2021 supports |
Modern synthetic problem list
| Grade | Problem | Clinical status | Verification | Placement | Historical claims |
|---|---|---|---|---|---|
| S | Breathlessness on exertion and tiredness since discharge three weeks after the heart attack, without chest pain at rest; cause to be determined (heart function, ischemia, anemia, medicine effect or deconditioning) | resolved | confirmed | active | |
| S | Coronary artery disease after a non-ST-elevation myocardial infarction three weeks before intake, treated with one drug-eluting stent to the right coronary artery; synthetic modern episode linked to the documented heart attack of March 1912 | active | confirmed | both_with_link | CLM-0011 |
| S | High blood pressure, found during the hospital stay for the heart attack | active | confirmed | active | |
| S | Absence of the uterus after an emergency hysterectomy at about 35, during a long, grave illness after the loss of a pregnancy; whether the ovaries were removed is not known; counted as a possible early menopause when weighing her cardiovascular risk | active | provisional | both_with_link | CLM-0007, CLM-0008 |
| S | Breathlessness from ticagrelor: a common, harmless side effect, resolved after the change to clopidogrel | resolved | confirmed | active | |
| S | Raised lipoprotein(a), 172 nmol/L, an inherited risk-enhancing factor | active | confirmed | active | |
| S | Financial strain: heavy debts after the loss of her home and estate, with income only from performing, which she has stopped while she recovers | active | confirmed | active | CLM-0010, CLM-0011 |
| S | Anterior nosebleed from the left side of the nose, lasting about 25 minutes, in dry weather on aspirin and clopidogrel; stopped with pressure; no further bleeding | resolved | confirmed | active |
Synthetic outcome measures
| Grade | Date | Measure | Result | Coding |
|---|---|---|---|---|
| S | 1969-04-14 | Hemoglobin [Mass/volume] in Blood | 12.2 g/dL Reference 11.6-15 g/dL |
http://loinc.org · 718-7 |
| S | 1969-04-14 | Platelets [#/volume] in Blood by Automated count | 264 10*3/uL Reference 150-400 10*3/uL |
http://loinc.org · 777-3 |
| S | 1969-04-14 | Sodium [Moles/volume] in Serum or Plasma | 139 mmol/L Reference 135-145 mmol/L |
http://loinc.org · 2951-2 |
| S | 1969-04-14 | Potassium [Moles/volume] in Serum or Plasma | 4.4 mmol/L Reference 3.5-5.1 mmol/L |
http://loinc.org · 2823-3 |
| S | 1969-04-14 | Creatinine [Mass/volume] in Serum or Plasma | 0.82 mg/dL Reference 0.59-1.04 mg/dL |
http://loinc.org · 2160-0 |
| S | 1969-04-14 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1964)/1.73 sq M | 81 mL/min/1.73 m² Reference >=60 mL/min/1.73 m² |
http://loinc.org · 98979-8 |
| S | 1969-04-14 | Glucose [Mass/volume] in Serum or Plasma | 94 mg/dL Reference 70-99 mg/dL |
http://loinc.org · 2345-7 |
| S | 1969-04-14 | Cholesterol [Mass/volume] in Serum or Plasma | 152 mg/dL Reference <=199 mg/dL |
http://loinc.org · 2093-3 |
| S | 1969-04-14 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | 84 mg/dL (high) Reference Secondary-prevention goal below 70 mg/dL |
http://loinc.org · 13457-7 |
| S | 1969-04-14 | Cholesterol in HDL [Mass/volume] in Serum or Plasma | 52 mg/dL Reference >=50 mg/dL |
http://loinc.org · 2085-9 |
| S | 1969-04-14 | Triglyceride [Mass/volume] in Serum or Plasma | 80 mg/dL Reference <=149 mg/dL |
http://loinc.org · 2571-8 |
| S | 1969-04-14 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 24 U/L Reference 7-35 U/L |
http://loinc.org · 1742-6 |
| S | 1969-04-14 | Hemoglobin A1c/Hemoglobin.total in Blood | 5.6% Reference <=5.6% |
http://loinc.org · 4548-4 |
| S | 1969-04-14 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 2 | http://loinc.org · 55758-7 |
| S | 1969-04-14 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 7 | http://loinc.org · 44261-6 |
| S | 1969-04-14 | Overall summary score [SAQ] | 70 | http://loinc.org · 88474-2 |
| S | 1969-04-28 | Lipoprotein a [Moles/volume] in Serum or Plasma | 172 nmol/L (high) Reference 125 nmol/L or higher is a risk-enhancing level |
http://loinc.org · 43583-4 |
| S | 1969-04-28 | Left ventricular Ejection fraction | 52% Reference 50-70% |
http://loinc.org · 10230-1 |
| S | 1969-05-26 | Sodium [Moles/volume] in Serum or Plasma | 140 mmol/L Reference 135-145 mmol/L |
http://loinc.org · 2951-2 |
| S | 1969-05-26 | Potassium [Moles/volume] in Serum or Plasma | 4.7 mmol/L Reference 3.5-5.1 mmol/L |
http://loinc.org · 2823-3 |
| S | 1969-05-26 | Creatinine [Mass/volume] in Serum or Plasma | 0.88 mg/dL Reference 0.59-1.04 mg/dL |
http://loinc.org · 2160-0 |
| S | 1969-05-26 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1964)/1.73 sq M | 74 mL/min/1.73 m² Reference >=60 mL/min/1.73 m² |
http://loinc.org · 98979-8 |
| S | 1969-05-26 | Glucose [Mass/volume] in Serum or Plasma | 92 mg/dL Reference 70-99 mg/dL |
http://loinc.org · 2345-7 |
| S | 1969-05-26 | Overall summary score [SAQ] | 84 | http://loinc.org · 88474-2 |
| S | 1969-06-16 | Hemoglobin [Mass/volume] in Blood | 11.9 g/dL Reference 11.6-15 g/dL |
http://loinc.org · 718-7 |
| S | 1969-06-16 | Platelets [#/volume] in Blood by Automated count | 258 10*3/uL Reference 150-400 10*3/uL |
http://loinc.org · 777-3 |
| S | 1969-07-21 | Cholesterol [Mass/volume] in Serum or Plasma | 128 mg/dL Reference <=199 mg/dL |
http://loinc.org · 2093-3 |
| S | 1969-07-21 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | 62 mg/dL Reference Secondary-prevention goal below 70 mg/dL |
http://loinc.org · 13457-7 |
| S | 1969-07-21 | Cholesterol in HDL [Mass/volume] in Serum or Plasma | 54 mg/dL Reference >=50 mg/dL |
http://loinc.org · 2085-9 |
| S | 1969-07-21 | Triglyceride [Mass/volume] in Serum or Plasma | 72 mg/dL Reference <=149 mg/dL |
http://loinc.org · 2571-8 |
| S | 1969-07-21 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 22 U/L Reference 7-35 U/L |
http://loinc.org · 1742-6 |
| S | 1969-07-21 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 3 | http://loinc.org · 44261-6 |
| S | 1969-07-21 | Overall summary score [SAQ] | 94 | http://loinc.org · 88474-2 |
| S | 1969-09-15 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 0 | http://loinc.org · 55758-7 |
| S | 1969-10-20 | Hemoglobin [Mass/volume] in Blood | 12.4 g/dL Reference 11.6-15 g/dL |
http://loinc.org · 718-7 |
| S | 1969-10-20 | Sodium [Moles/volume] in Serum or Plasma | 139 mmol/L Reference 135-145 mmol/L |
http://loinc.org · 2951-2 |
| S | 1969-10-20 | Potassium [Moles/volume] in Serum or Plasma | 4.5 mmol/L Reference 3.5-5.1 mmol/L |
http://loinc.org · 2823-3 |
| S | 1969-10-20 | Creatinine [Mass/volume] in Serum or Plasma | 0.84 mg/dL Reference 0.59-1.04 mg/dL |
http://loinc.org · 2160-0 |
| S | 1969-10-20 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1964)/1.73 sq M | 78 mL/min/1.73 m² Reference >=60 mL/min/1.73 m² |
http://loinc.org · 98979-8 |
| S | 1969-10-20 | Glucose [Mass/volume] in Serum or Plasma | 93 mg/dL Reference 70-99 mg/dL |
http://loinc.org · 2345-7 |
| S | 1969-10-20 | Overall summary score [SAQ] | 96 | http://loinc.org · 88474-2 |
| S | 1969-09-15 | Total score [AUDIT-C] | 1 | http://loinc.org · 75626-2 |
Synthetic vital signs
| Date | Measure | Result | LOINC | Grade |
|---|---|---|---|---|
| 1969-04-14 | Body height | 168 cm | 8302-2 | S |
| 1969-04-14 | Body weight | 59.8 kg | 29463-7 | S |
| 1969-04-14 | Body mass index (BMI) [Ratio] | 21.2 kg/m2 | 39156-5 | S |
| 1969-04-14 | Systolic blood pressure | 138 mm[Hg] | 8480-6 | S |
| 1969-04-14 | Diastolic blood pressure | 84 mm[Hg] | 8462-4 | S |
| 1969-04-14 | Heart rate | 64 /min | 8867-4 | S |
| 1969-04-14 | Respiratory rate | 16 /min | 9279-1 | S |
| 1969-04-14 | Body temperature | 36.6 Cel | 8310-5 | S |
| 1969-04-14 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 % | 59408-5 | S |
| 1969-04-28 | Body height | 168 cm | 8302-2 | S |
| 1969-04-28 | Body weight | 59.6 kg | 29463-7 | S |
| 1969-04-28 | Body mass index (BMI) [Ratio] | 21.1 kg/m2 | 39156-5 | S |
| 1969-04-28 | Systolic blood pressure | 136 mm[Hg] | 8480-6 | S |
| 1969-04-28 | Diastolic blood pressure | 82 mm[Hg] | 8462-4 | S |
| 1969-04-28 | Heart rate | 62 /min | 8867-4 | S |
| 1969-04-28 | Respiratory rate | 16 /min | 9279-1 | S |
| 1969-04-28 | Body temperature | 36.7 Cel | 8310-5 | S |
| 1969-04-28 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 % | 59408-5 | S |
| 1969-05-26 | Body height | 168 cm | 8302-2 | S |
| 1969-05-26 | Body weight | 59.9 kg | 29463-7 | S |
| 1969-05-26 | Body mass index (BMI) [Ratio] | 21.2 kg/m2 | 39156-5 | S |
| 1969-05-26 | Systolic blood pressure | 126 mm[Hg] | 8480-6 | S |
| 1969-05-26 | Diastolic blood pressure | 78 mm[Hg] | 8462-4 | S |
| 1969-05-26 | Heart rate | 60 /min | 8867-4 | S |
| 1969-05-26 | Respiratory rate | 14 /min | 9279-1 | S |
| 1969-05-26 | Body temperature | 36.6 Cel | 8310-5 | S |
| 1969-05-26 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 % | 59408-5 | S |
| 1969-07-21 | Body height | 168 cm | 8302-2 | S |
| 1969-07-21 | Body weight | 60.4 kg | 29463-7 | S |
| 1969-07-21 | Body mass index (BMI) [Ratio] | 21.4 kg/m2 | 39156-5 | S |
| 1969-07-21 | Systolic blood pressure | 122 mm[Hg] | 8480-6 | S |
| 1969-07-21 | Diastolic blood pressure | 76 mm[Hg] | 8462-4 | S |
| 1969-07-21 | Heart rate | 58 /min | 8867-4 | S |
| 1969-07-21 | Respiratory rate | 14 /min | 9279-1 | S |
| 1969-07-21 | Body temperature | 36.5 Cel | 8310-5 | S |
| 1969-07-21 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 % | 59408-5 | S |
| 1969-10-20 | Body height | 168 cm | 8302-2 | S |
| 1969-10-20 | Body weight | 60.6 kg | 29463-7 | S |
| 1969-10-20 | Body mass index (BMI) [Ratio] | 21.5 kg/m2 | 39156-5 | S |
| 1969-10-20 | Systolic blood pressure | 122 mm[Hg] | 8480-6 | S |
| 1969-10-20 | Diastolic blood pressure | 74 mm[Hg] | 8462-4 | S |
| 1969-10-20 | Heart rate | 58 /min | 8867-4 | S |
| 1969-10-20 | Respiratory rate | 14 /min | 9279-1 | S |
| 1969-10-20 | Body temperature | 36.6 Cel | 8310-5 | S |
| 1969-10-20 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 % | 59408-5 | S |
| 1969-06-16 | Body height | 168 cm | 8302-2 | S |
| 1969-06-16 | Body weight | 60.2 kg | 29463-7 | S |
| 1969-06-16 | Body mass index (BMI) [Ratio] | 21.3 kg/m2 | 39156-5 | S |
| 1969-06-16 | Systolic blood pressure | 132 mm[Hg] | 8480-6 | S |
| 1969-06-16 | Diastolic blood pressure | 80 mm[Hg] | 8462-4 | S |
| 1969-06-16 | Heart rate | 70 /min | 8867-4 | S |
| 1969-06-16 | Respiratory rate | 16 /min | 9279-1 | S |
| 1969-06-16 | Body temperature | 36.6 Cel | 8310-5 | S |
| 1969-06-16 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 % | 59408-5 | S |
| 1969-09-15 | Body height | 168 cm | 8302-2 | S |
| 1969-09-15 | Body weight | 60.6 kg | 29463-7 | S |
| 1969-09-15 | Body mass index (BMI) [Ratio] | 21.5 kg/m2 | 39156-5 | S |
| 1969-09-15 | Systolic blood pressure | 124 mm[Hg] | 8480-6 | S |
| 1969-09-15 | Diastolic blood pressure | 76 mm[Hg] | 8462-4 | S |
| 1969-09-15 | Heart rate | 58 /min | 8867-4 | S |
| 1969-09-15 | Respiratory rate | 14 /min | 9279-1 | S |
| 1969-09-15 | Body temperature | 36.6 Cel | 8310-5 | S |
| 1969-09-15 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 % | 59408-5 | S |
Social, functional, and mental status
Social history
- S Entertainer, singer and dancer for more than forty years, in Paris and on tours around the world; has stopped performing while she recovers and wants to return to the stage
- S Veteran of the wartime Resistance, decorated for intelligence work, and a civil rights activist who has spoken against segregation all her life
- S Mother of twelve adopted children, some still at school; the family recently lost the home and estate where she raised them, and now lives in a rented house
- S Finances: large debts from the estate; income only from performing, which has stopped since the heart attack; she is anxious about the cost of medicines and of the children's needs
- S Tobacco: never. Alcohol: rarely, a glass of champagne on occasion. No drug use
- S Diet: irregular meals around rehearsals and travel, often late at night; enjoys cooking for her family; little salt added
- S Says she waited until the morning to go to hospital, thinking the pressure in her chest was the strain of the eviction; asks that her account of her body be taken seriously and that she be told plainly what each medicine is for
Functional status
- S Independent in all daily activities; breathless after one flight of stairs or ten minutes of brisk walking, which before the heart attack never limited her; has not danced since
Mental status
- S Alert, warm and direct; worried about her family and her debts, and grieving the loss of her home; sleeps poorly; PHQ-9 score 7 with no thoughts of self-harm
Allergies and medications
Allergies
- S No known allergy
Medications
- S Aspirin 81 mg delayed-release oral tablet, one tablet daily
- S Ticagrelor 90 mg oral tablet, one tablet twice daily
- S Clopidogrel 75 mg oral tablet: a 600 mg loading dose (eight tablets) 24 hours after the last ticagrelor, then one tablet daily
- S Atorvastatin 80 mg oral tablet, one tablet daily
- S Metoprolol succinate 25 mg extended-release oral tablet, one tablet daily
- S Lisinopril 5 mg oral tablet, one tablet daily
- S Lisinopril 10 mg oral tablet, one tablet daily
- S Nitroglycerin 0.4 mg sublingual tablet, one tablet under the tongue every 5 minutes as needed for chest pain, up to 3 tablets; call 911 if the pain is not better 5 minutes after the first tablet
Procedures and immunizations
Procedures
- S Coronary angiography and percutaneous coronary intervention in the hospital for a non-ST-elevation myocardial infarction: 90% stenosis of the mid right coronary artery treated with one drug-eluting stent; mild disease elsewhere. Performed at a regional hospital before she established care
- S Twelve-lead electrocardiogram: sinus rhythm at 64 per minute, small Q waves in II, III and aVF from the recent inferior infarction, no acute ST change, normal QT
- S Outpatient cardiac rehabilitation, phase 2: 36 sessions over twelve weeks with exercise training, nutrition, stress management and psychological support; all sessions completed
- S Transthoracic echocardiography: ejection fraction 52%, hypokinesis of the basal and mid inferior wall, normal right ventricle, no thrombus, normal valves, normal estimated filling pressures, no pericardial effusion
- S Symptom-limited exercise treadmill test on her usual medicines (Bruce protocol): 9 minutes, about 10 METs, peak heart rate 132 per minute on metoprolol, normal blood pressure response (124/76 to 172/80), no angina, no ischemic ST change, no arrhythmia
- S Advance care planning conversation, about 20 minutes, with her consent
Immunizations
- S 1969-09-15: Influenza vaccine, this season
- S 1969-09-15: COVID-19 vaccine, mRNA, this season
- S 1969-09-15: Pneumococcal conjugate vaccine PCV20, single dose
- S 1969-10-20: Respiratory syncytial virus vaccine, single dose
- S 1969-10-20: Recombinant zoster vaccine, dose 1 of 2
- S 1969-10-20: Tetanus, diphtheria, and acellular pertussis vaccine (Tdap)
Past medical history
True biography with historical dates; not part of the synthetic care timeline.
- R June 1941 to December 1942: Long, grave illness in Casablanca after the loss of a pregnancy: in bed in hospital from June 1941 to December 1942, with five operations, reportedly including an emergency hysterectomy, and peritonitis and septicemia (details from one secondary source; stillbirth or miscarriage disputed) (CLM-0007, CLM-0008)
- D March 1969: Heart attack in March 1969, on the day of her eviction from Les Milandes, with admission to hospital in Périgueux; described as a new heart attack, with any earlier one undated in the sources read (CLM-0011)
Family history
No family medical history is documented in the logged sources. Family history of real relatives is never synthesized.
Care-plan goals
| Goal | Target date | Status | Outcome |
|---|---|---|---|
| Twelve months of dual antiplatelet therapy from the heart attack without interruption | 1970-03-24 | active | Seven months completed without a missed dose; changed from ticagrelor to clopidogrel without a gap |
| LDL cholesterol below 70 mg/dL with at least a 50% fall | 1969-07-21 | completed | LDL 62 mg/dL, a 58% fall from 146 |
| Blood pressure below 130/80 mmHg | 1969-05-26 | completed | 126/78 in the clinic; home average 124/76 |
| Complete cardiac rehabilitation and return to performing | 1969-07-21 | completed | Exercise test to about 10 METs without ischemia; graded return to rehearsals agreed |
| Mood: PHQ-9 below 5 by twelve weeks | 1969-07-21 | completed | PHQ-9 7 to 3 |
Interventions
| Intervention | Status | Guideline |
|---|---|---|
| Respectful, trauma-informed shared decisions: take her account of her symptoms seriously, explain each medicine and its reason plainly, write the plan down, and check costs with her before prescribing | completed | GL-AHA-WOMEN-MI-2016, GL-GWTG-DISPARITY-2016, GL-CCD-2023 |
| Cardiology consultation on the day of the two-week visit, with an echocardiogram, to find the cause of the breathlessness, review the antiplatelet choice and the other medicines, and advise on rehabilitation and a return to the stage | completed | GL-CCD-2023, GL-ACS-2025, GL-CMID-2026 |
| Dual antiplatelet therapy, aspirin 81 mg with a P2Y12 inhibitor, for twelve months from the heart attack, never stopped without speaking to cardiology; then aspirin alone | completed | GL-ACS-2025, GL-CCD-2023, GL-CMID-2026 |
| Atorvastatin 80 mg daily; lipid panel four to eight weeks after the start; goal LDL below 70 mg/dL with at least a 50% fall; lipoprotein(a) measured once | completed | GL-CCD-2023, GL-CMID-2026 |
| Metoprolol succinate for at least the first year after the heart attack; lisinopril for high blood pressure, with home readings and a target below 130/80 mmHg; potassium and creatinine one to two weeks after any dose change | completed | GL-CCD-2023, GL-CMID-2026 |
| Enroll in a 36-session outpatient cardiac rehabilitation program, starting within two weeks, with exercise training, nutrition, stress management and psychological support; the clinic will call her if she misses sessions | completed | GL-CCD-2023, GL-AHA-WOMEN-MI-2016, GL-CMID-2026 |
| Depression after a heart attack: PHQ-2 and PHQ-9 today, repeat PHQ-9 at about twelve weeks, the rehabilitation program's psychologist, and a lower threshold for treatment if symptoms rise | completed | GL-AHA-DEP-2008, GL-AHA-DEP-ACS-2014, GL-CCD-2023 |
| Chest-pain action plan: nitroglycerin under the tongue, and 911 if pain is not better five minutes after the first tablet; warning symptoms in women, such as breathlessness, unusual tiredness, nausea or jaw, back or arm discomfort, explained | completed | GL-AHA-WOMEN-MI-2016, GL-CCD-2023 |
| Costs: generic medicines in 90-day fills, the clinic social worker for debt advice and help with medicine costs, and rehabilitation sessions at times that fit her family | completed | GL-CCD-2023 |
| Women's cardiovascular risk: record the hysterectomy of her thirties and a possible early menopause as a risk-enhancing factor; hormone therapy is not used to prevent heart disease | completed | GL-AHA-MENO-2020, GL-AHA-WOMEN-MI-2016 |
| Change ticagrelor to clopidogrel for ticagrelor-related breathlessness: 600 mg loading dose 24 hours after the last ticagrelor, then 75 mg daily, without a gap in antiplatelet cover | completed | GL-ACS-2025, GL-CCD-2023 |
| Raise lisinopril to 10 mg daily for blood pressure above target, with potassium and creatinine one to two weeks later | completed | GL-CCD-2023, GL-CMID-2026 |
| Laboratory tests drawn at the rehabilitation center on session days, so that no check needs a separate trip | completed | GL-CMID-2026 |
| Nosebleed plan on dual antiplatelet therapy: firm pressure on the soft part of the nose for 15 minutes, saline spray and a humidifier; do not stop aspirin or clopidogrel; come in if bleeding lasts more than 30 minutes | completed | GL-AAO-EPISTAXIS-2020, GL-ACS-2025 |
| Graded return to the stage: rehearsals at the effort reached in rehabilitation, then full performances, with rest between shows, water, and nitroglycerin in the dressing room | completed | GL-CCD-2023 |
Planned encounters
- 1969-04-14 — Establishing care three weeks after a heart attack and stent, with breathlessness on exertion and tiredness: examination, ECG, laboratory tests, medicines, mood screening, cardiac rehabilitation and the chest-pain action plan (ENC-001)
- 1969-04-28 — Two-week review: echocardiogram, cardiology consultation the same day, the cause of the breathlessness and the antiplatelet plan (ENC-002)
- 1969-05-26 — Four-week review after the change to clopidogrel: breathlessness, blood pressure, potassium and kidney function, and cardiac rehabilitation (ENC-003)
- 1969-06-16 — Same-day sick visit for a nosebleed on dual antiplatelet therapy (ENC-006, unscheduled)
- 1969-07-21 — Twelve-week review: exercise test, lipids, mood, and the return to performing (ENC-004)
- 1969-09-15 — Periodic adult preventive visit (ENC-007)
- 1969-10-20 — Seven-month review: antiplatelet plan to twelve months, blood pressure, kidney function, angina status and plans for the year (ENC-005)
Supporting documents
- History and physical
- Progress note 01
- Progress note 02 — Focused Visit (Follow-up)
- Progress note 03 — Focused Visit (Follow-up)
- Progress note 04 — Sick Visit
- Progress note 05 — Focused Visit (Follow-up)
- Progress note 06 — Preventive Visit
- Progress note 07 — Focused Visit (Care-plan review)
- Cardiology referral
- Cardiology consultation
- Patient care plan
- Teaching note
- Provenance CSV
C-CDA note documents
Each link opens a readable copy; the XML beside it is the exchange file.
- History and physical (XML)
- Progress note 01 (XML)
- Progress note 02 — Focused Visit (Follow-up) (XML)
- Progress note 03 — Focused Visit (Follow-up) (XML)
- Progress note 04 — Sick Visit (XML)
- Progress note 05 — Focused Visit (Follow-up) (XML)
- Progress note 06 — Preventive Visit (XML)
- Progress note 07 — Focused Visit (Care-plan review) (XML)
- Cardiology referral (XML)
- Cardiology consultation (XML)
Sources
| ID | Source | Publisher | Type |
|---|---|---|---|
| SRC-0001 | Joséphine Baker (Chemins de mémoire: personnalités) | Ministère des Armées, France (Direction de la mémoire, de la culture et des archives) | government |
| SRC-0002 | Josephine Baker | National Park Service (a National Historic Site in Washington, D.C.) | government |
| SRC-0003 | Raspiengeas JC. Joséphine Baker: les mille vies du Phénix (dossier). La Croix L'Hebdo, November 2021 | Bayard Presse (La Croix), reproduced by the Château des Milandes | other |
| SRC-0004 | Ojala JA. Baker, Josephine (1906-1975). Women in World History: A Biographical Encyclopedia | Gale, via Encyclopedia.com | biography |
| SRC-0005 | Munro S. Josephine Baker (1906-1975). Women's History Network blog | Women's History Network | biography |
| SRC-0006 | Call for donations from Josephine Baker for the safeguarding of her castle in the Dordogne (television clip, June 2, 1964) | Institut national de l'audiovisuel (INA) | other |
| SRC-0007 | Josephine Baker | Biography.com (A&E Television Networks) | biography |
| SRC-0008 | Josephine Baker (Feminism and French Women in History: famous French women) | Library of Congress research guide | government |
| SRC-0009 | HISTMED Master Roster v3 | The Human Record project | other |
| SRC-0010 | Josephine Baker (biography) | National Women's History Museum | biography |
Review status
| Review | Status | Notes |
|---|---|---|
| schema validation | not_started | Run scripts/build.ps1 -Conformance. |
| clinical review | not_started | Awaiting clinician review; check the attribution of breathlessness to ticagrelor and the switch to clopidogrel with a 600 mg load, twelve months of dual antiplatelet therapy, metoprolol with an ejection fraction of 52%, lisinopril for blood pressure, the missed potassium check, the nosebleed managed without stopping antiplatelets, the exercise test before a return to the stage, the hysterectomy counted as a possible early menopause, and PHQ-9 scores below 10 without a safety assessment. |
| provenance review | not_started | Sources: the French Ministry of the Armed Forces, the National Park Service, a La Croix dossier hosted by the Château des Milandes, Women in World History, the Women's History Network, the INA archive, Biography.com, a Library of Congress guide and the National Women's History Museum. The Panthéon (Centre des monuments nationaux) site, the Smithsonian NMAAHC page and the New York Times obituary could not be fetched; Jean-Claude Baker's and Bennetta Jules-Rosette's books were not read. A heart attack in 1964 could not be verified and is not used. |
| safe messaging review | not_started | Poverty, racism, the pregnancy loss and the eviction are recorded plainly as history, without graphic detail. The claim about the pregnancy loss and hysterectomy is marked sensitive. Mood screening is synthetic and below the threshold for a safety assessment. Her adopted children are not named, and no relative or other real person is given a modern statement, decision or health fact. |
Comments and corrections
Sign in with GitHub to comment on this record. To report a specific error, ideally with a source, use the feedback form; each report becomes a tracked issue.
Comments appear on the online version of this page.